Press "Enter" to skip to content

New patent for Teva Pharm drug ARMONAIR RESPICLICK

0
Copyright © DrugPatentWatch. Originally published at New patent for Teva Pharm drug ARMONAIR RESPICLICK

Annual Drug Patent Expirations for ARMONAIR+RESPICLICK
Annual Drug Patent Expirations for ARMONAIR+RESPICLICK

Armonair Respiclick is a drug marketed by Teva Pharm and is included in one NDA. It is available from one supplier. There are thirteen patents protecting this drug.

Drug patent litigation for ARMONAIR RESPICLICK.

The generic ingredient in ARMONAIR RESPICLICK is fluticasone propionate. One supplier is listed for this compound. Additional details are available on the fluticasone propionate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent for Teva Pharm drug ARMONAIR RESPICLICK
Find your next blockbuster

Get accurate and timely intelligence — in just a few clicks

✓ Free trial

✓ No credit card

 

DrugPatentWatch - Make Better Decisions